Neuron-Specific Enolase (NSE)

Original price was: ₹6,400.00.Current price is: ₹4,499.00.

Neuron-Specific Enolase (NSE) Test

The Neuron-Specific Enolase (NSE) test measures the level of NSE, an enzyme found in neuronal and neuroendocrine cells. This test is primarily used as a tumor marker and in evaluating neurological disorders.


Why is the NSE Test Done?

Cancer Diagnosis & Monitoring:

  • Small Cell Lung Cancer (SCLC) – NSE is a key tumor marker
  • Neuroendocrine Tumors – Carcinoid tumors, pheochromocytomas, medullary thyroid carcinoma
  • Neuroblastoma – Helps in diagnosis, staging, and prognosis

Neurological Conditions:

  • Traumatic Brain Injury (TBI) – NSE can indicate neuronal damage
  • Stroke – Higher levels may suggest ischemic or hemorrhagic stroke
  • Neurodegenerative Diseases – Elevated in Alzheimer’s disease, Parkinson’s disease, and Creutzfeldt-Jakob disease

Assess Hypoxic Brain Injury (e.g., after cardiac arrest)


How is the Test Performed?

🔬 Sample Type: Blood (Serum/Plasma) or CSF (Cerebrospinal Fluid)
📌 NSE levels in CSF are more specific for neuronal damage than in blood.


Interpreting NSE Levels

NSE Level (ng/mL) Interpretation Possible Causes
<12 ng/mL Normal No significant neuronal injury or tumor presence
12-25 ng/mL Mild elevation Possible mild neuronal injury (e.g., stroke, TBI)
>25 ng/mL Significantly elevated Suggestive of SCLC, neuroblastoma, severe brain damage

📌 A rising NSE level in cancer patients suggests tumor progression or recurrence.
📌 A decreasing NSE level after treatment indicates a positive response.


Limitations & Important Considerations

NSE is NOT a standalone diagnostic tool – It should be interpreted along with imaging and clinical findings.
Hemolysis (ruptured red blood cells) can falsely elevate NSE – Proper sample handling is crucial.
Other conditions (e.g., chronic kidney disease, hemolytic diseases) can mildly raise NSE levels.


Next Steps After an Abnormal NSE Test

🔬 If elevated:
✔ Further testing with CT/MRI, PET scans for cancer or neurological damage
Monitor serial NSE levels in cancer patients to track treatment response